Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB
HONG KONG, Jul 7, 2022 – (ACN Newswire via SEAPRWire.com) – Jiangsu Huili Biotechnology Co., Ltd (“Huili Bio”), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB. This financing round was co-led by Legend Capital and the fresh capital will be... » read more